Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

McMaster University

$19,880.00

Biophotonics technology for minimally invasive in-vivo diagnosis

EF 2007-08

Résumé
Biophotonics (or biomedical optics) is a fast growing interdisciplinary field in which recent physical, chemical, and engineering advances are applied to meet biological and medical challenges. Optical energy can be used to accurately and precisely detect certain changes in the biological system in terms of its localization, volume, energy, time, and spectra. Particularly, the use of fiber optic catheters enables minimally invasive delivery and detection of optical energy in very remote regions of the human body. Fluorescence-based spectroscopy and imaging techniques are important thrusts in biophotonics.  When light is onto biological tissue, some tissue molecules will emit fluorescence light containing intrinsic information about these fluorophores (collagen, elastin, lipids, NADH, flavin, vitamin, amino acids etc.) Fluorescence spectroscopy techniques acquire and analyze this emitted light to characterize the biochemical composition and pathological conditions of the living biological system. They have played important roles in developing minimally-invasive diagnostic modalities for both basic and clinical research. In addition to naturally occurring fluorophores, synthesized exogenous fluorescent dyes have been used to target specific malignant cells or intracellular species (e.g. mitochondria and/or membrane). Advances in such technologies will have broad applicability such as early detection and diagnosis of malignant conditions, image-guided interventions, and monitoring responses to therapy, which will ultimately benefit Canada's health care system.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
327384-2006
Name nom
Fang, Qiyin
Department département
Engineering Physics
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2006
Award amount
19880
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
29
Committee name en
General Physics
Committee name fr
Physique générale
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
2
Nb partie
3
Application title
Biophotonics technology for minimally invasive in-vivo diagnosis
Keyword
NA
Application summary
Biophotonics (or biomedical optics) is a fast growing interdisciplinary field in which recent physical, chemical, and engineering advances are applied to meet biological and medical challenges. Optical energy can be used to accurately and precisely detect certain changes in the biological system in terms of its localization, volume, energy, time, and spectra. Particularly, the use of fiber optic catheters enables minimally invasive delivery and detection of optical energy in very remote regions of the human body. Fluorescence-based spectroscopy and imaging techniques are important thrusts in biophotonics.  When light is onto biological tissue, some tissue molecules will emit fluorescence light containing intrinsic information about these fluorophores (collagen, elastin, lipids, NADH, flavin, vitamin, amino acids etc.) Fluorescence spectroscopy techniques acquire and analyze this emitted light to characterize the biochemical composition and pathological conditions of the living biological system. They have played important roles in developing minimally-invasive diagnostic modalities for both basic and clinical research. In addition to naturally occurring fluorophores, synthesized exogenous fluorescent dyes have been used to target specific malignant cells or intracellular species (e.g. mitochondria and/or membrane). Advances in such technologies will have broad applicability such as early detection and diagnosis of malignant conditions, image-guided interventions, and monitoring responses to therapy, which will ultimately benefit Canada's health care system.